Lori Laffel, MD, MPH is Chief of the Pediatric, Adolescent
and Young Adult Section and Head of the Section on Clinical, Behavioral and
Outcomes Research at the Joslin Diabetes Center, as well as a Professor of
Pediatrics at Harvard Medical School.
Dr. Laffel’s research aims to prevent the late complications
of Type 1 and Type 2 diabetes and preserve the health, normal growth,
development, and family functioning of children, adolescents, and young adults
with diabetes. A major focus of Dr. Laffel’s research is the use of
technologies, such as CGM, automated insulin delivery, and text messaging
systems, in diabetes management. She is an expert in the area of CGM use in
youth with Type 1 diabetes and was co-chair of the landmark multi-site JDRF CGM
RCT. Dr. Laffel is also a Principal Investigator and member of the National
Steering Committee for the NIH-funded TODAY study, the largest clinical trial
involving youth with Type 2 diabetes to date. Dr. Laffel has published more
than 200 peer-reviewed research articles.
Dr. Laffel has served on numerous advisory committees for
the American Diabetes Association (ADA) and the JDRF. She is the co-editor of
the ADA/JDRF Sourcebook on Type 1 Diabetes through the Life Span. She is also a
current member of the JDRF's Research Advisory Committee. Dr. Laffel has
received multiple awards, including the 2015 American Diabetes Association
Outstanding Physician-Clinician Award, the 2016 Greater Boston Chamber of
Commerce Pinnacle Award, and the 2016 University of Miami Miller School of
Medicine Hall of Fame Award.
Dr. Laffel received her MD from the University of Miami
School of Medicine and her MPH from the Harvard School of Public Health. She
completed her post-doctoral training at Boston Children's Hospital and the
Joslin Diabetes Center.